*|MC:SUBJECT|*
BioFIT 2021
View this email in your browser

Dear BioRN Members,


Come and join us at the 10th edition of BioFIT December 7th to 9th, 2021 | Digital format

With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation deals and pre-seed, seed and Series A investment in the field of Life Sciences.

BioRN is supporting the event as a Partner and we are glad to offer to our members 10% discount on regular fees until October 30th to attend the conference.
Use the discount code: BF21BioRN20121.


Annalisa and the BioRN Team
WHY ATTEND BIOFIT?
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:
  • of collaborative research projects
  • of licensing deals
  • of equity investment deals
  • of services deals
Estimate based on the measurement of 2018 and 2019 delegates’ outcomes.
 
KEY FIGURES OF BIOFIT & MedFIT 2020:
  • delegates
  • 2,500 One-on-one meetings scheduled
  • countries represented
  • 14 conferences // 68 speakers
  • 68 exhibitors
  • 62 innovative projects presented
  • 1,000 deals generated in 2019
 
INSIDE THE EVENT:  
PARTICIPANTS:
  • Pharma: Almirall | Astellas Pharma | Bayer | Boehringer Ingelheim | GSK | Ipsen Innovation | Kyowa Kirin Pharmaceutical | Lilly | Maruho Co | Merck | MSD | Novo Nordisk | Pfizer | Roche | Sanofi | Servier | Thea Open Innovation…
  • Veterinary: Bayer Animal Health | Boehringer Ingelheim Animal Health | Ceva Animal Health | MSD Animal Health | Vetoquinol | Virbac | Zoetis...
  • Biotech and Diag: Evotec | Genfit | Innate Pharma | LFB | Syngulon…
  • TTOs and academia: Ascenion | CNRS | EMBLEM | INRA | Inserm Transfert | King’s College | LifeArc | Max Planck Institute | NIH | Oxford University | Princeton University | Technion | TNO | Yissum...
  • Investors (pre-seed, seed, Series A): Abingworth | Advent France Biotechnology Asabys Partners | BioGeneration VenturesEarlybird Europen Investment Bank | Fournier-Majoie Foundation Hadean Ventures | High-Tech Gründerfonds Kurma Partners | Medicxi | M Ventures | Novo Seeds Seventure Partners | Sofinnova Partners | Theodorus Turenne Capital...
Please check out the different participants’ lists of the previous editions, as well as the list of last year’s edition >>here<<.
 
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*